BFC Planning, Inc.’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$146K Buy
3,412
+960
+39% +$52.1K 0.01% 1070
2026
Q1
$154K Buy
2,452
+382
+18% +$30.6K 0.01% 961
2025
Q4
$197K Sell
2,070
-248
-11% -$24.3K 0.01% 872
2025
Q3
$226K Sell
2,318
-74,777
-97% -$7.74M 0.02% 629
2025
Q2
$8.28M Sell
77,095
-928
-1% -$93.9K 0.65% 24
2025
Q1
$7.87M Sell
78,023
-2,550
-3% -$257K 0.69% 20
2024
Q4
$7.2M Buy
+80,573
New +$7.09M 0.6% 28

Other funds holding BSX

BFC Planning, Inc.'s BSX Position: Q2 2026 in Review

BFC Planning, Inc. increased its Boston Scientific (BSX) stake by 39% in Q2 2026, buying an estimated $52.1K and bringing the position to 3,412 shares worth $146K. The position accounts for 0.01% of the portfolio, ranked #1070.

BFC Planning, Inc. first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.28M in Q2 2025. 1,491 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • BFC Planning, Inc. held 3,412 shares of Boston Scientific worth $146K as of Q2 2026.
  • BFC Planning, Inc. bought 960 Boston Scientific shares in Q2 2026, an estimated $52.1K.
  • Boston Scientific made up 0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #1070 holding.
  • BFC Planning, Inc. first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • BFC Planning, Inc.'s Boston Scientific position peaked at $8.28M in Q2 2025.
  • 1,491 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.